INMB icon

INmune Bio
INMB

Overview Fund Activity

28 hedge funds and large institutions have $10.3M invested in INmune Bio in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+12
Holders Change %
+75%
% of All Funds
0.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
6
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
GPCM
1
Granite Point Capital Management
Massachusetts
$2.58M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.13M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$1.03M
4
EI
4
EAM Investors
California
$760K
5
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$651K

Top Sellers

1
FAIM
1
Financial Advocates Investment Management
Washington
$187K
2
TRCT
2
Tower Research Capital (TRC)
New York
$6K
3
BlackRock
3
BlackRock
New York
$190K
4
PAG
4
Private Advisor Group
New Jersey
$0
5
UBS Group
5
UBS Group
Switzerland
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
PFS
26
Prospera Financial Services
Texas
$2K +$2K +175 New
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$1K +$29 +3 +3%
UBS Group
28
UBS Group
Switzerland
– -$4K -820 Closed
PAG
29
Private Advisor Group
New Jersey
– -$4K -675 Closed
1
2